Arvee Laboratories (India) Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Company is almost debt free
- Stock looks reasonably valued - P/E of 49.2 is below its historical median
- Company comfortably covers its interest (12.6x coverage)
- Company generates healthy free cash flow
CONS
- Operating cash flow has been negative in recent years
- Company has a low return on equity of 8.9% over last 3 years
- Company's sales have been declining over the last five years
- Company has delivered a poor profit growth of -1.4% over past five years
- Operating margins have contracted to 9.4% from 15.2%
- Stock is trading at 5.0x its book value
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SOLARINDS | 22307.50 | 101.37 | 201860.69 | 0.05 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| PIDILITIND | 1567.45 | 60.23 | 159547.55 | 1.37 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| SRF | 2483.00 | 34.05 | 73602.28 | 0.36 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| FLUOROCHEM | 4771.75 | 85.23 | 52417.67 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 9.58 | 26.83 |
| NAVINFLUOR | 8541.10 | 55.49 | 43822.77 | 0.18 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| GODREJIND | 1127.00 | 32.29 | 37963.11 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| AETHER | 1672.95 | 94.41 | 22204.70 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| DEEPAKNTR | 1587.10 | 27.64 | 21646.94 | 0.47 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| ATUL | 6244.55 | 23.11 | 18385.05 | 0.48 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| AARTIIND | 492.15 | 33.62 | 17851.59 | 0.20 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.95 | 16.00 |
| DEEPAKFERT | 1320.45 | 17.00 | 16725.20 | 0.76 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| ARVEE | 180.69 | 49.19 | 199.12 | 0.00 | 1.69 | 896.47 | 17.23 | 130.28 | 10.00 | 14.49 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8 | 9 | 8 | 6 | 11 | 13 | 9 | 6 | 7 | 3 | 10 | 11 | 17 | |
| 7 | 8 | 7 | 5 | 9 | 11 | 9 | 6 | 7 | 3 | 8 | 10 | 15 | |
| Operating Profit | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 0 | 0 | 0 | 2 | 1 | 2 |
| OPM % | 13.03% | 7.74% | 6.88% | 12.87% | 14.43% | 12.05% | 3.93% | 3.41% | 4.55% | 3.77% | 16.56% | 10.19% | 12.24% |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
| Tax % | 24.62% | 25.00% | 25.00% | 79.31% | 25.40% | 25.19% | 23.81% | 33.33% | 5.88% | 0.00% | -31.65% | 38.82% | 25.99% |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 2 |
| 0.44 | 0.19 | 0.22 | 0.11 | 0.85 | 0.89 | 0.14 | 0.06 | 0.15 | 0.01 | 1.66 | 0.47 | 1.54 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 27 | 34 | 48 | 55 | 45 | 47 | 40 | 61 | 30 | 38 | 41 | |
| 22 | 29 | 41 | 49 | 39 | 41 | 35 | 54 | 27 | 35 | 36 | |
| Operating Profit | 5 | 6 | 7 | 6 | 6 | 6 | 6 | 7 | 3 | 4 | 5 |
| OPM % | 17.52% | 16.30% | 15.01% | 11.25% | 13.26% | 12.75% | 13.95% | 11.87% | 9.68% | 9.38% | 12.02% |
| 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Interest | 3 | 3 | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Profit before Tax | 1 | 1 | 2 | 3 | 3 | 4 | 3 | 6 | 2 | 3 | 5 |
| Tax % | 65.00% | -80.38% | 43.15% | 11.05% | 25.61% | 26.48% | 25.38% | 33.19% | 42.51% | 25.20% | 10.69% |
| Net Profit | 0 | 2 | 1 | 2 | 2 | 3 | 3 | 4 | 1 | 2 | 4 |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.24 | 2.34 | 3.74 | 0.95 | 1.95 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 11%
- 5 Years:
- -3%
- 3 Years:
- -2%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- -1%
- 3 Years:
- -6%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- 15%
- 3 Years:
- 16%
- 1 Year:
- 11%
RETURN ON EQUITY
- 10 Years:
- 15%
- 5 Years:
- 10%
- 3 Years:
- 9%
- Last Year:
- 7%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 6 | 6 | 6 | 11 | 11 | 11 | 11 | 11 |
| -1 | 0 | 9 | 11 | 13 | 10 | 13 | 17 | 18 | 20 | |
| 24 | 24 | 15 | 11 | 4 | 9 | 3 | 1 | 1 | 1 | |
| Trade Payables | 6 | 6 | 12 | 6 | 10 | 10 | 10 | 8 | 7 | 3 |
| 3 | 2 | 3 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | |
| Total Liabilities | 35 | 36 | 44 | 37 | 34 | 41 | 39 | 39 | 39 | 38 |
| 13 | 17 | 15 | 13 | 13 | 14 | 14 | 13 | 13 | 15 | |
| Capital Work in Progress | 4 | 0 | 1 | 2 | 2 | 1 | 1 | 2 | 3 | 1 |
| 0 | 0 | 0 | 2 | 3 | 2 | 0 | 0 | 0 | 0 | |
| 7 | 6 | 8 | 5 | 6 | 7 | 6 | 5 | 6 | 5 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 8 | |
| Cash & Bank | 1 | 1 | 2 | 4 | 1 | 7 | 5 | 1 | 2 | 5 |
| 9 | 12 | 18 | 12 | 8 | 10 | 14 | 19 | 9 | 4 | |
| Total Assets | 35 | 36 | 44 | 37 | 34 | 41 | 39 | 39 | 39 | 38 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 3 | 7 | 10 | 11 | 3 | 5 | 5 | 4 | -0 | |
| Cash from Investing | -5 | -1 | -1 | -3 | -3 | -1 | 0 | -1 | -2 | -1 |
| Cash from Financing | -1 | -3 | -4 | -5 | -10 | 5 | -6 | -2 | -0 | -0 |
| 0 | -0 | 1 | 2 | -3 | 6 | -2 | -1 | 1 | -2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-09 - Arvee Laboratories (India) Limited has informed the Exchange regarding Cessation of Mrs Raina Singh as Company Secretary & Compliance Officer of the company w.e.f. September 09, 2026.
2026-08-07 - Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-04 - Arvee Laboratories (India) Limited has informed the Exchange regarding Corrigendum to Other
2026-06-27 - Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
2026-06-15 - Shalin Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
2026-05-19 - Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
News
Recent coverage and analyst commentary for ARVEE
Loading news…
AI Stock Analyst
Arvee Laboratories (India) Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account